Cargando…

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder

BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system. Although complement-dependent astrocyte damage mediated by anti-aquaporin 4 autoantibody (AQP4-Ab) is well acknowledged to be the core of NMOSD pathogenesis, additional inflammatory c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Kazuya, Kinoshita, Makoto, Miyamoto, Katsuichi, Namba, Akiko, Shimizu, Mikito, Koda, Toru, Sugimoto, Tomoyuki, Mori, Yuki, Yoshioka, Yoshichika, Nakatsuji, Yuji, Kumanogoh, Atsushi, Kusunoki, Susumu, Mochizuki, Hideki, Okuno, Tatsusada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924507/ https://www.ncbi.nlm.nih.gov/pubmed/29703264 http://dx.doi.org/10.1186/s12974-018-1162-0

Ejemplares similares

Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation
por: Shimizu, Mikito, et al.
Publicado: (2020)

Beneficial effects of fingolimod in MS patients with high serum Sema4A levels
por: Koda, Toru, et al.
Publicado: (2018)

Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats
por: Ishikura, Teruyuki, et al.
Publicado: (2021)

Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase
por: Koda, Toru, et al.
Publicado: (2020)

Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder
por: Murata, Hisashi, et al.
Publicado: (2022)

Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
por: Araki, Manabu, et al.
Publicado: (2014)

Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica
por: Harada, Kana, et al.
Publicado: (2018)

High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)
por: Beppu, Shohei, et al.
Publicado: (2022)

Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner
por: Honorat, Josephe A., et al.
Publicado: (2017)

Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder
por: Matsuoka, Takako, et al.
Publicado: (2023)

Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET
por: Kato, Hiroki, et al.
Publicado: (2020)

Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese
por: Ogawa, Kotaro, et al.
Publicado: (2019)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Miyamoto, Katsuichi, et al.
Publicado: (2023)

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data
por: Watanabe, Mitsuru, et al.
Publicado: (2021)

(11)C-Acetate PET Imaging in Patients with Multiple Sclerosis
por: Takata, Kazushiro, et al.
Publicado: (2014)

Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2019)

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
por: Papp, Viktoria, et al.
Publicado: (2021)

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
por: Bai, Shumei, et al.
Publicado: (2009)

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2017)

Reply to comment on: Dietary yeasts reduce inflammation in central nervous system via microflora
por: Takata, Kazushiro, et al.
Publicado: (2015)

Dietary Yeasts Reduce Inflammation in Central Nerve System via Microflora
por: Takata, Kazushiro, et al.
Publicado: (2015)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis
por: Tada, Satoru, et al.
Publicado: (2014)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica
por: Mori, Masahiro, et al.
Publicado: (2011)

Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders
por: Li, Jinghong, et al.
Publicado: (2022)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

The Lactic Acid Bacterium Pediococcus acidilactici Suppresses Autoimmune Encephalomyelitis by Inducing IL-10-Producing Regulatory T Cells
por: Takata, Kazushiro, et al.
Publicado: (2011)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica
por: Kariya, Yoshinobu, et al.
Publicado: (2015)

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
por: Marignier, R., et al.
Publicado: (2016)

Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
por: Shu, Yaqing, et al.
Publicado: (2016)

BAFF Controls Neural Cell Survival through BAFF Receptor
por: Tada, Satoru, et al.
Publicado: (2013)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mimg46607repe6fqm33jq9b6fq